Impact analysis of heart failure across European countries: an ESC-HFA position paper

Giuseppe M C Rosano; Petar Seferovic; Gianluigi Savarese; Ilaria Spoletini; Yuri Lopatin; Fin Gustafsson; Antoni Bayes-Genis; Tiny Jaarsma; Magdy Abdelhamid; Arantxa Gonzalez Miqueo; Massimo Piepoli; Carlo G Tocchetti; Arsen D Ristić; Ewa Jankowska; Brenda Moura; Loreena Hill; Gerasimos Filippatos; Marco Metra; Davor Milicic; Thomas Thum; Ovidiu Chioncel; Tuvia Ben Gal; Lars H Lund; Dimitrios Farmakis; Wilfried Mullens; Stamatis Adamopoulos; Michael Bohm; Anna Norhammar; Andreas Bollmann; Amitava Banerjee; Aldo P Maggioni; Adriaan Voors; Alain Cohen Solal; Andrew J S Coats

doi:10.1002/ehf2.14076

Impact analysis of heart failure across European countries: an ESC-HFA position paper

Giuseppe M C Rosano, Petar Seferovic, Gianluigi Savarese, Ilaria Spoletini, Yuri Lopatin, Fin Gustafsson, Antoni Bayes-Genis, Tiny Jaarsma, Magdy Abdelhamid, Arantxa Gonzalez Miqueo, Massimo Piepoli, Carlo G Tocchetti, Arsen D Ristić, Ewa Jankowska, Brenda Moura, Loreena Hill, Gerasimos Filippatos, Marco Metra, Davor Milicic, Thomas ThumOvidiu Chioncel, Tuvia Ben Gal, Lars H Lund, Dimitrios Farmakis, Wilfried Mullens, Stamatis Adamopoulos, Michael Bohm, Anna Norhammar, Andreas Bollmann, Amitava Banerjee, Aldo P Maggioni, Adriaan Voors, Alain Cohen Solal, Andrew J S Coats

Research output: Contribution to journal › Review article › peer-review

5 Downloads (Pure)

Abstract

Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geographical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prevalence, outcomes, and human costs-in terms of quality of life-in European countries.

Original language	English
Pages (from-to)	2767-2778
Number of pages	12
Journal	ESC heart failure
Volume	9
Issue number	5
Early online date	22 Jul 2022
DOIs	https://doi.org/10.1002/ehf2.14076
Publication status	Published - Oct 2022

Keywords

Epidemiology
Heart failure
Impact
Morbidity
Mortality
Prognosis
Quality of life

Access to Document

10.1002/ehf2.14076Licence: CC BY-NC

ESC Heart Failure - 2022 - Rosano - Impact analysis of heart failure across European countries an ESC‐HFA position paperFinal published version, 13.3 MBLicence: CC BY-NC

Cite this

Rosano, G. M. C., Seferovic, P., Savarese, G., Spoletini, I., Lopatin, Y., Gustafsson, F., Bayes-Genis, A., Jaarsma, T., Abdelhamid, M., Miqueo, A. G., Piepoli, M., Tocchetti, C. G., Ristić, A. D., Jankowska, E., Moura, B., Hill, L., Filippatos, G., Metra, M., Milicic, D., ... Coats, A. J. S. (2022). Impact analysis of heart failure across European countries: an ESC-HFA position paper. ESC heart failure, 9(5), 2767-2778. https://doi.org/10.1002/ehf2.14076

@article{b78523c332634b67a9df6ec1942c3429,

title = "Impact analysis of heart failure across European countries: an ESC-HFA position paper",

abstract = "Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geographical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prevalence, outcomes, and human costs-in terms of quality of life-in European countries.",

keywords = "Epidemiology, Heart failure, Impact, Morbidity, Mortality, Prognosis, Quality of life",

author = "Rosano, {Giuseppe M C} and Petar Seferovic and Gianluigi Savarese and Ilaria Spoletini and Yuri Lopatin and Fin Gustafsson and Antoni Bayes-Genis and Tiny Jaarsma and Magdy Abdelhamid and Miqueo, {Arantxa Gonzalez} and Massimo Piepoli and Tocchetti, {Carlo G} and Risti{\'c}, {Arsen D} and Ewa Jankowska and Brenda Moura and Loreena Hill and Gerasimos Filippatos and Marco Metra and Davor Milicic and Thomas Thum and Ovidiu Chioncel and {Ben Gal}, Tuvia and Lund, {Lars H} and Dimitrios Farmakis and Wilfried Mullens and Stamatis Adamopoulos and Michael Bohm and Anna Norhammar and Andreas Bollmann and Amitava Banerjee and Maggioni, {Aldo P} and Adriaan Voors and Solal, {Alain Cohen} and Coats, {Andrew J S}",

note = "Publisher Copyright: {\textcopyright} 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.",

year = "2022",

month = oct,

doi = "10.1002/ehf2.14076",

language = "English",

volume = "9",

pages = "2767--2778",

number = "5",

}

Rosano, GMC, Seferovic, P, Savarese, G, Spoletini, I, Lopatin, Y, Gustafsson, F, Bayes-Genis, A, Jaarsma, T, Abdelhamid, M, Miqueo, AG, Piepoli, M, Tocchetti, CG, Ristić, AD, Jankowska, E, Moura, B, Hill, L, Filippatos, G, Metra, M, Milicic, D, Thum, T, Chioncel, O, Ben Gal, T, Lund, LH, Farmakis, D, Mullens, W, Adamopoulos, S, Bohm, M, Norhammar, A, Bollmann, A, Banerjee, A, Maggioni, AP, Voors, A, Solal, AC & Coats, AJS 2022, 'Impact analysis of heart failure across European countries: an ESC-HFA position paper', ESC heart failure, vol. 9, no. 5, pp. 2767-2778. https://doi.org/10.1002/ehf2.14076

TY - JOUR

T1 - Impact analysis of heart failure across European countries

T2 - an ESC-HFA position paper

AU - Rosano, Giuseppe M C

AU - Seferovic, Petar

AU - Savarese, Gianluigi

AU - Spoletini, Ilaria

AU - Lopatin, Yuri

AU - Gustafsson, Fin

AU - Bayes-Genis, Antoni

AU - Jaarsma, Tiny

AU - Abdelhamid, Magdy

AU - Miqueo, Arantxa Gonzalez

AU - Piepoli, Massimo

AU - Tocchetti, Carlo G

AU - Ristić, Arsen D

AU - Jankowska, Ewa

AU - Moura, Brenda

AU - Hill, Loreena

AU - Filippatos, Gerasimos

AU - Metra, Marco

AU - Milicic, Davor

AU - Thum, Thomas

AU - Chioncel, Ovidiu

AU - Ben Gal, Tuvia

AU - Lund, Lars H

AU - Farmakis, Dimitrios

AU - Mullens, Wilfried

AU - Adamopoulos, Stamatis

AU - Bohm, Michael

AU - Norhammar, Anna

AU - Bollmann, Andreas

AU - Banerjee, Amitava

AU - Maggioni, Aldo P

AU - Voors, Adriaan

AU - Solal, Alain Cohen

AU - Coats, Andrew J S

PY - 2022/10

Y1 - 2022/10

N2 - Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geographical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prevalence, outcomes, and human costs-in terms of quality of life-in European countries.

AB - Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geographical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prevalence, outcomes, and human costs-in terms of quality of life-in European countries.

KW - Epidemiology

KW - Heart failure

KW - Impact

KW - Morbidity

KW - Mortality

KW - Prognosis

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=85134550148&partnerID=8YFLogxK

U2 - 10.1002/ehf2.14076

DO - 10.1002/ehf2.14076

M3 - Review article

C2 - 35869679

SN - 2055-5822

VL - 9

SP - 2767

EP - 2778

JO - ESC heart failure

JF - ESC heart failure

IS - 5

ER -

Impact analysis of heart failure across European countries: an ESC-HFA position paper

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this